Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dynamic Changes in the Levels of Amyloid-β42 Species in the Brain and Periphery of APP/PS1 Mice and Their Significance for Alzheimer’s Disease
Liding Zhang, Changwen Yang, Yanqing Li, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 20

Showing 20 citing articles:

Sensitive detection of multiple blood biomarkers via immunomagnetic exosomal PCR for the diagnosis of Alzheimer’s disease
Hu Shun, Liding Zhang, Ying Su, et al.
Science Advances (2024) Vol. 10, Iss. 13
Open Access | Times Cited: 19
Ultrasensitive and point-of-care detection of plasma phosphorylated tau in Alzheimer’s disease using colorimetric and surface-enhanced Raman scattering dual-readout lateral flow assay
Liding Zhang, Ying Su, Xiaohan Liang, et al.
Nano Research (2023) Vol. 16, Iss. 5, pp. 7459-7469
Open Access | Times Cited: 24
Aβ42 and ROS dual-targeted multifunctional nanocomposite for combination therapy of Alzheimer’s disease
Liding Zhang, Kai Cao, Jun Xie, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Mesoporous silica nanoparticle-encapsulated Bifidobacterium attenuates brain Aβ burden and improves olfactory dysfunction of APP/PS1 mice by nasal delivery
Ni Liu, Changwen Yang, Xiaohan Liang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 23
Plant‐derived peptides for the improvement of Alzheimer's disease: Production, functions, and mechanisms
Like Lin, Cong Li, Tingting Li, et al.
Food Frontiers (2023) Vol. 4, Iss. 2, pp. 677-699
Open Access | Times Cited: 14
Fluorescent Fingerprint Identification of Protein Structural Changes and Disease-Specific Amyloid Beta Aggregates Based on a Single-Nanozyme Sensor Array
Xiaohai Yang, Min Zhang, Na Lü
Analytical Chemistry (2025)
Closed Access
Nanozyme sensor array based on manganese dioxide for the distinction between multiple amyloid β peptides and their dynamic aggregation process
Shun Hu, Changwen Yang, Yanqing Li, et al.
Biosensors and Bioelectronics (2021) Vol. 199, pp. 113881-113881
Closed Access | Times Cited: 25
Quantitative assessment of AD markers using naked eyes: point-of-care testing with paper-based lateral flow immunoassay
Liding Zhang, Xuewei Du, Ying Su, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 23
The emerging role of the microbiome in Alzheimer's disease
Caroline Wasén, Ella Simonsen, Millicent N. Ekwudo, et al.
International review of neurobiology (2022), pp. 101-139
Open Access | Times Cited: 15
Cerebrospinal fluid and blood biomarkers in the diagnostic assays of Alzheimer’s disease
Liding Zhang, Xiaohan Liang, Zhihong Zhang, et al.
Journal of Innovative Optical Health Sciences (2021) Vol. 15, Iss. 01
Open Access | Times Cited: 18
Dual-targeted magnetic mesoporous silica nanoparticles reduce brain amyloid-β burden via depolymerization and intestinal metabolism
Ni Liu, Xiaohan Liang, Changwen Yang, et al.
Theranostics (2022) Vol. 12, Iss. 15, pp. 6646-6664
Open Access | Times Cited: 13
Highly sensitive blood-based biomarkers detection of beta-amyloid and phosphorylated-tau181 for Alzheimer’s disease
Wei Yang, Fulin Guan, Lihui Yang, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 2
Rapid, scalable assay of amylin-β amyloid co-aggregation in brain tissue and blood
Deepak Kotiya, Noah S Leibold, Nirmal Verma, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 5, pp. 104682-104682
Open Access | Times Cited: 6
Elevated Plasma Oligomeric Amyloid β-42 Is Associated with Cognitive Impairments in Cerebral Small Vessel Disease
Wensheng Qu, Liding Zhang, Xiaohan Liang, et al.
Biosensors (2023) Vol. 13, Iss. 1, pp. 110-110
Open Access | Times Cited: 5
An In Situ Study on Nanozyme Performance to Optimize Nanozyme-Strip for Aβ Detection
Yaying Luo, Haiming Luo, Sijia Zou, et al.
Sensors (2023) Vol. 23, Iss. 7, pp. 3414-3414
Open Access | Times Cited: 2
Evolution of Detecting Early Onset of Alzheimer’s Disease: From Neuroimaging to Optical Immunoassays
Wesley Wei‐Wen Hsiao, Stefanny Angela, Trong‐Nghia Le, et al.
Journal of Alzheimer s Disease (2023) Vol. 93, Iss. 3, pp. 821-845
Closed Access | Times Cited: 2
Emerging nanotherapeutic strategies targeting gut-X axis against diseases
Ao Sun, Hongyu Liu, Mengchi Sun, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115577-115577
Open Access | Times Cited: 2
Impaired Hippocampal Reactivation Preceding Robust Aβ Deposition in a Model of Alzheimer’s Disease
Hanyan Li, Zhuoyang Zhao, Aline Fassini, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Gut dysbiosis contributes to the development of Budd-Chiari syndrome through immune imbalance
Qinwei Lu, Rongtao Zhu, Lin Zhou, et al.
mSystems (2024) Vol. 9, Iss. 9
Open Access
Aβ42 and ROS Dual-targeted Multifunctional Nanocomposite for Combination Therapy of Alzheimer’s Disease
Liding Zhang, Kai Cao, Jun Xie, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top